The study concluded that there may be clinical benefit to the use of GLP1-RA in MCAS but as this was an observational study, there were no controls
Investigating differential responses based on patient demographics, genetic profiles, and specific pain conditions will also be crucial in developing personalized treatment strategies, thereby optimizing the therapeutic benefits of GLP-1R agonists for diverse patient populations
Excessive or poorly targeted antioxidant intervention could theoretically alter normal signalling as well as damaging oxidation
Susini et al., 1998) (Figure 3)
Ways to Access Affordable GLP-1 Treatment For patients seeking GLP-1 treatment, several strategies may help reduce costs or improve access, though options remain limited compared to many other medications
If GLP-1s are affecting different parts of the body, you might wonder what else it might be affecting